Polycystic Ovarian Syndrome: Role of Imaging in Diagnosis

被引:36
作者
Lee, Tony T. [1 ]
Rausch, Mary E. [2 ]
机构
[1] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Radiol, Bronx, NY 10467 USA
[2] Hofstra Univ, Hofstra N Shore LIJ Sch Med, Ctr Human Reprod, Manhasset, NY USA
关键词
STROMAL ECHOGENICITY; METABOLIC SYNDROME; WOMEN; ULTRASOUND; VOLUME; ENDOCRINE; PREVALENCE; OVULATION; PREDICTORS; AMENORRHEA;
D O I
10.1148/rg.326125503
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Polycystic ovarian syndrome (PCOS) is the most common endocrine abnormality in women of reproductive age and carries with it significant health risks, including infertility, endometrial hyperplasia, diabetes, and cardiovascular disease. The workup of PCOS has evolved to include the use of pelvic ultrasonography (US). Ovarian imaging is crucial in the evaluation of patients with suspected PCOS. Although findings of polycystic ovaries are commonly seen at routine US and are frequently not associated with PCOS, awareness of the criteria and definitions used in the diagnosis of PCOS is important, especially in patients who are being evaluated for ovulatory dysfunction or hyperandrogenism. The imaging report should be specific and should include ovarian volumes and antral follicle counts, in addition to other pertinent findings (eg, the presence of a dominant follicle or corpus luteum). Because patients are frequently referred for radiologic imaging as a part of clinical workup, and polycystic ovaries are a common incidental finding in women undergoing US for other gynecologic complaints, radiologists should be aware of the current diagnostic criteria for PCOS, the role of imaging in workup for this abnormality, and the pertinent reporting parameters for pelvic US. (C)RSNA, 2012 . radiographics.rsna.org
引用
收藏
页码:1643 / 1657
页数:15
相关论文
共 57 条
  • [1] ADAMS J, 1985, LANCET, V2, P1375
  • [2] Ovarian stromal echogenicity in women with clomiphene citrate-sensitive and clomiphene citrate-resistant polycystic ovary syndrome
    Al-Took, S
    Watkin, K
    Tulandi, T
    Tan, SL
    [J]. FERTILITY AND STERILITY, 1999, 71 (05) : 952 - 954
  • [3] [Anonymous], 2009, Obstet Gynecol, V114, P936, DOI 10.1097/AOG.0b013e3181bd12cb
  • [4] [Anonymous], AM J MED
  • [5] Ultrasound criteria in the diagnosis of polycystic ovary syndrome (PCOS)
    Atiomo, WU
    Pearson, S
    Shaw, S
    Prentice, A
    Dubbins, P
    [J]. ULTRASOUND IN MEDICINE AND BIOLOGY, 2000, 26 (06) : 977 - 980
  • [6] The prevalence and features of the polycystic ovary syndrome in an unselected population
    Azziz, R
    Woods, KS
    Reyna, R
    Key, TJ
    Knochenhauer, ES
    Yildiz, BO
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (06) : 2745 - 2749
  • [7] Troglitazone improves ovulation and hirsutism in the polycystic ovary syndrome: A multicenter, double blind, placebo-controlled trial
    Azziz, R
    Ehrmann, D
    Legro, RS
    Whitcomb, RW
    Hanley, R
    Fereshetian, AG
    O'Keefe, M
    Ghazzi, MN
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (04) : 1626 - 1632
  • [8] The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report
    Azziz, Ricardo
    Carmina, Enrico
    Dewailly, Didier
    Diamanti-Kandarakis, Evanthia
    Escobar-Morreale, Hector F.
    Futterweit, Walter
    Janssen, Onno E.
    Legro, Richard S.
    Norman, Robert J.
    Taylor, Ann E.
    Witchel, Selina F.
    [J]. FERTILITY AND STERILITY, 2009, 91 (02) : 456 - 488
  • [9] Polycystic ovary syndrome and cancer
    Balen, A
    [J]. HUMAN REPRODUCTION UPDATE, 2001, 7 (06) : 522 - 525
  • [10] Ultrasound assessment of the polycystic ovary: international consensus definitions
    Balen, AH
    Laven, JSE
    Tan, SL
    Dewailly, D
    [J]. HUMAN REPRODUCTION UPDATE, 2003, 9 (06) : 505 - 514